Natixis Advisors, L.P. Embecta Corp. Transaction History
Natixis Advisors, L.P.
- $54.1 Billion
- Q1 2025
A detailed history of Natixis Advisors, L.P. transactions in Embecta Corp. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 25,284 shares of EMBC stock, worth $296,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,284
Previous 33,268
24.0%
Holding current value
$296,581
Previous $687,000
53.13%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EMBC
# of Institutions
409Shares Held
56.4MCall Options Held
54.8KPut Options Held
32.3K-
Black Rock Inc. New York, NY9.19MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$79 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.81MShares$44.7 Million0.03% of portfolio
-
River Road Asset Management, LLC3.23MShares$37.9 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.72MShares$31.9 Million0.88% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $678M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...